Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 31 | $1,356,323 |
Sells | 242 | $370,430,422 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jun 2024 10:40 | SNPS | SYNOPSYS INC | DE GEUS AART | EXECUTIVE CHAIR | 24 Jun 2024 | Sale | 2,535 | 600.9854 | 1,523,498 | D |
26 Jun 2024 10:43 | TTMI | TTM TECHNOLOGIES INC | FARRELL ROBERT P. | President C&C | 24 Jun 2024 | Sale | 5,159 | 18.9911 | 97,975 | D |
26 Jun 2024 10:35 | PGR | PROGRESSIVE CORP/OH/ | BROZ STEVEN | Chief Information Officer | 24 Jun 2024 | Sale | 3,050 | 209.81 | 639,920 | D |
26 Jun 2024 10:37 | TTMI | TTM TECHNOLOGIES INC | SANCHEZ TONY | VP, Corporate Controller | 24 Jun 2024 | Sale | 6,940 | 18.9969 | 131,838 | D |
26 Jun 2024 08:40 | CRNC | Cerence Inc | ORTMANNS STEFAN | Chief Executive Officer | 24 Jun 2024 | Sale | 9,542 | 3.294 | 31,431 | D |
26 Jun 2024 06:02 | NCNO | nCino Inc | INSIGHT HOLDINGS GROUP, LLC | Director , 10% | 24 Jun 2024 | Sale | 17,710 | 31.5297 | 558,391 | I |
26 Jun 2024 06:02 | NCNO | nCino Inc | INSIGHT HOLDINGS GROUP, LLC | Director , 10% | 24 Jun 2024 | Sale | 26,784 | 31.5297 | 844,491 | I |
26 Jun 2024 06:02 | NCNO | nCino Inc | INSIGHT HOLDINGS GROUP, LLC | Director , 10% | 24 Jun 2024 | Sale | 5,181 | 31.5297 | 163,355 | I |
26 Jun 2024 06:02 | NCNO | nCino Inc | INSIGHT HOLDINGS GROUP, LLC | Director , 10% | 24 Jun 2024 | Sale | 15,730 | 31.5297 | 495,962 | I |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 100 | 4 | 400 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 107 | 3.75 | 401 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 100 | 3.5 | 350 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 200 | 3.2 | 640 | D |
26 Jun 2024 17:31 | DLTR | DOLLAR TREE Inc | AFLATOONI ROBERT | Chief Information Officer | 25 Jun 2024 | Sale | 827 | 105.58 | 87,315 | D |
26 Jun 2024 17:37 | PPTINC | Presidio Property Trust Inc | HEILBRON JACK KENDRICK | Chief Executive Officer | 25 Jun 2024 | Purchase | 6,000 | 0.64 | 3,840 | D |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 396 | 164.3817 | 65,095 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 350 | 163.5232 | 57,233 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 50 | 168.14 | 8,407 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 4,021 | 167.6113 | 673,965 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 2,204 | 166.5707 | 367,122 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 927 | 165.6224 | 153,532 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 350 | 163.5235 | 57,233 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 50 | 168.14 | 8,407 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 2,204 | 166.5706 | 367,122 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 4,022 | 167.6112 | 674,132 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 927 | 165.6215 | 153,531 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 395 | 164.3803 | 64,930 | I |
26 Jun 2024 17:16 | CRM | Salesforce Inc | MILLHAM BRIAN | President and COO | 25 Jun 2024 | Sale | 1,662 | 242 | 402,204 | D |
26 Jun 2024 17:10 | LOCL | Local Bounti Corp | NELSON MARK JOSEPH | Director | 25 Jun 2024 | Sale | 8,405 | 2.6808 | 22,532 | D |
26 Jun 2024 17:10 | ACIC | AMERICAN COASTAL INSURANCE Corp | GRIFFITH CHRISTOPHER | Chief Operating Officer | 25 Jun 2024 | Sale | 35,000 | 10.49 | 367,150 | D |
26 Jun 2024 17:12 | CRM | Salesforce Inc | HARRIS PARKER | Co-Founder and CTO, Slack | 25 Jun 2024 | Sale | 559 | 242.4382 | 135,523 | D |
26 Jun 2024 17:12 | CRM | Salesforce Inc | HARRIS PARKER | Co-Founder and CTO, Slack | 25 Jun 2024 | Sale | 1,266 | 241.5922 | 305,856 | D |
26 Jun 2024 17:12 | CRM | Salesforce Inc | HARRIS PARKER | Co-Founder and CTO, Slack | 25 Jun 2024 | Sale | 975 | 240.6165 | 234,601 | D |
26 Jun 2024 17:06 | OB | Outbrain Inc | GALAI YARON | Director | 25 Jun 2024 | Sale | 277 | 4.95 | 1,371 | D |
26 Jun 2024 17:00 | DDOG | Datadog Inc | ACOCELLA KERRY | General Counsel and Secretary | 25 Jun 2024 | Sale | 3,857 | 120.032 | 462,963 | D |
26 Jun 2024 16:57 | HTGC | Hercules Capital Inc | CROWELL GAYLE A | Director | 25 Jun 2024 | Purchase | 701.6 | 20.0499 | 14,067 | D |
26 Jun 2024 16:59 | CIFR | Cipher Mining Inc | BITFURY TOP HOLDCO B.V. | 10% | 25 Jun 2024 | Sale | 454,073 | 4.26 | 1,934,351 | I |
26 Jun 2024 16:46 | NABL | N-able Inc | PAI KATHLEEN | EVP, Chief People Officer | 25 Jun 2024 | Sale | 300 | 15 | 4,500 | D |
26 Jun 2024 16:39 | NXDT | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | DONDERO JAMES D | See Remarks, 10% | 25 Jun 2024 | Purchase | 45,552 | 5.09 | 231,860 | I |
26 Jun 2024 16:39 | PGY | Pagaya Technologies Ltd. | PERROS EVANGELOS | Chief Financial Officer | 25 Jun 2024 | Sale | 11,293 | 12.1461 | 137,166 | D |
26 Jun 2024 16:40 | HCP | HashiCorp Inc | ST. LEDGER SUSAN | President, Worldwide Field Ops | 25 Jun 2024 | Sale | 3,264 | 33.448 | 109,174 | D |
26 Jun 2024 16:44 | HQY | HEALTHEQUITY Inc | KESSLER JON | PRESIDENT AND CEO | 25 Jun 2024 | Sale | 2,781 | 83.0782 | 231,040 | I |
26 Jun 2024 16:44 | HQY | HEALTHEQUITY Inc | KESSLER JON | PRESIDENT AND CEO | 25 Jun 2024 | Sale | 6,675 | 83.0782 | 554,547 | D |
26 Jun 2024 16:38 | ORGN | Origin Materials Inc | HEIDENMARK COOK PIA JOHANNA | Director | 25 Jun 2024 | Sale | 4,640 | 0.9844 | 4,568 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 164 | 321.82 | 52,778 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 886 | 320.0237 | 283,541 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 1,853 | 319.1057 | 591,303 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 697 | 318.4362 | 221,950 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | MESA NILDA | Director | 25 Jun 2024 | Sale | 266 | 318.5784 | 84,742 | D |
26 Jun 2024 16:31 | NUVB | Nuvation Bio Inc | CUI XIANGMIN | Director | 25 Jun 2024 | Purchase | 277,895 | 2.97 | 825,348 | I |
26 Jun 2024 16:32 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 25 Jun 2024 | Sale | 3,000 | 45.37 | 136,110 | D |
26 Jun 2024 16:24 | IOT | Samsara Inc | BICKET JOHN | SEE REMARKS, 10% | 25 Jun 2024 | Sale | 96,000 | 29.4912 | 2,831,155 | I |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 25 Jun 2024 | Purchase | 6,685 | 1.45 | 9,693 | I |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 125 | 235.19 | 29,399 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 138 | 234.66 | 32,383 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 86 | 233.53 | 20,084 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 161 | 232.54 | 37,439 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 74 | 231.59 | 17,138 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 227 | 229.93 | 52,194 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 198 | 229.06 | 45,354 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 96 | 228.3 | 21,917 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 26 | 226.82 | 5,897 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 13 | 225.55 | 2,932 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 9 | 224.17 | 2,018 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 45 | 221.71 | 9,977 | D |
26 Jun 2024 16:26 | IOT | Samsara Inc | BISWAS SANJIT | CHIEF EXECUTIVE OFFICER, 10% | 25 Jun 2024 | Sale | 96,000 | 29.4917 | 2,831,203 | I |
26 Jun 2024 16:26 | RVMD | Revolution Medicines Inc | KELSEY STEPHEN MICHAEL | See Remarks | 25 Jun 2024 | Sale | 16,467 | 39.057 | 643,152 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 957 | 234.66 | 224,570 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 863 | 235.19 | 202,969 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 595 | 233.53 | 138,950 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,119 | 232.54 | 260,212 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 511 | 231.59 | 118,342 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,572 | 229.93 | 361,450 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,374 | 229.06 | 314,728 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 666 | 228.3 | 152,048 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 177 | 226.82 | 40,147 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)